Pathfinder
Basket vs. Umbrella Clinical Trials: Which Precision Oncology Trial Design Is Better?
Pharma's Almanac
PAO-26-PF-16Jul 17, 2026
Pathfinder
Adaptive Trials vs. Traditional Randomized Controlled Trials: Which Clinical Trial Design Is Better?
Pharma's Almanac
PAO-26-PF-14Jul 3, 2026
Basket Trials
Basket Trials and the Future of Rare Cancer Research
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-26-PA-02Jul 2, 2026
Pathfinder
Site-Based vs. Decentralized vs. Hybrid Clinical Trials: Which Model Is Best for Modern Clinical Research?
Pharma's Almanac
PAO-26-PF-13Jun 26, 2026
Adaptive Trials
Designing for Change: Adaptive Clinical Trials and the Evolving Path to Regulatory Acceptance
Pharma's Almanac
PAO-06-26-PA-12Jun 19, 2026
CNS Clinical
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969
Insilico Medicine
PR-06-26-01Jun 17, 2026
Expedited Pathways
Accelerated Pathways: Are They Delivering on Their Promise?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-10Jun 17, 2026
Clinical Evidence
Rethinking Clinical Evidence Requirements in Rare Diseases
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-09Jun 16, 2026
Clinical Trial Needs
Bridging the Gap: Addressing Unmet Needs in Cardiology, Neuroscience, and Respiratory Trials
Bethany Davis, M.D.
Trialmed
PAO-04-26-CL-04May 1, 2026
Neuro Biomarkers
Precision Neurology: How Biomarkers Are Redefining Clinical Trial Design
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-26-PA-08Apr 13, 2026
Clinical Partnership
Quotient Sciences and Biorasi Partner to Accelerate Early Phase Clinical Trials to Patient Proof-of-Concept
Quotient Sciences
PR-04-26-04Apr 1, 2026
Drug Development
Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials
Quotient Sciences
PR-04-26-03Apr 1, 2026
CKD
The Expanding Therapeutic Landscape in Chronic Kidney Disease
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-26-PA-07Mar 11, 2026
Clinical Recruitment
Breaking Down Barriers in Cardiology Trials to Expand Access to At-Risk Populations
Karen Faulkner, M.D.; Madhu Venkate Gowda, M.D.
Trialmed
PAO-02-26-CL-03Mar 4, 2026
Early-Phase Trials
Innovations in Early-Phase Clinical Trials: Pioneering the Future of Medicine
Craig Boyle. M.D.
Trialmed
PAO-02-26-CL-05Mar 2, 2026
GCP
How Fully Owned, Locally Led Site Networks Deliver Quality, Speed, and Scalability in the Era of ICH E6(R3)
Łukasz Wiech, MD, MBA
Trialmed
PAO-02-26-CL-04Feb 23, 2026
Cardiovascular
Redefining Cardiovascular Disease Treatment Through Innovation and Prevention
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-02-26-NI-01Feb 2, 2026
Recruitment
Transforming Effective Patient Recruitment within the Changing Healthcare Landscape
Altair Silva; Sarah Rudolph; Zhe Rachel Angerer
PPD clinical research business of Thermo Fisher Scientific
PAO-01-26-CL-02Jan 22, 2026
Clinical Packaging
Inspection-Ready or Inspection-Exposed? Clinical Packaging Under Regulatory Scrutiny
David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-26-NI-10Jan 10, 2026
Clinical Blinding
Blinding Reconsidered: Why Trial Integrity Depends on More Than a Checkbox
David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-26-NI-09Jan 10, 2026